FDA OKs First Cancer Drug by Genetic Type, Not Organ of Origin

WEDNESDAY, May 24, 2017 -- Many new cancer drugs target genetic " biomarkers " that are specific to tumors -- wherever in the body they may appear. So on Tuesday, the U.S. Food and Drug Administration announced that, for the first time, it had...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news